Scritto da Annals of the Rheumatic Diseases current issue
Objective
To investigate frequencies and reasons for switching, treatment responses and drug survival in patients with ankylosing spondylitis (AS) switching tumour-necrosis-factor-α inhibitor (TNFi) treatment in routine clinic ... ...
Scritto da Annals of the Rheumatic Diseases current issue
Objectives
Tumour necrosis factor inhibition plus methotrexate is believed to inhibit radiographic progression independent of inflammation. This analysis assessed whether these protective effects are exerted on bone (joint erosion; ... ...
Scritto da Annals of the Rheumatic Diseases current issue
Purpose
To determine the sensitivity to change of the US7 score among RA patients under various therapies and to analyze the effect of each therapeutic option over 1 year. To estimate predictors for development of destructive bone c ... ...
Scritto da Annals of the Rheumatic Diseases current issue
Objectives
To investigate whether methotrexate or tumour necrosis factor inhibitors (TNFi) affect osteophyte formation in patients with psoriatic arthritis (PsA).
Scritto da Annals of the Rheumatic Diseases current issue
Background
Recent hospital-based studies have suggested a sixfold increased risk of pulmonary embolism (PE) in rheumatoid arthritis (RA) in the year following admission. We evaluated the risk of PE and deep vein thrombosis (DVT) and ... ...
Scritto da Annals of the Rheumatic Diseases current issue
Objectives
To evaluate the risk of incident myocardial infarction (MI), stroke and peripheral vascular disease (PVD) in individuals with systemic sclerosis (SSc) in a general population context.